Biotech | October 15, 2021
Exelixis in-licenses second anti-cancer compound from Aurigene
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
U.S. FDA has accepted the investigational new drug application for phase 1 clinical trial in non-Hodgkin’s lymphoma
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
Transformational partnership establishes PCI as a CDMO and broadens capabilities across drug product lifecycle
The Pune centre expands its presence beyond Bangalore and Hyderabad
Gantenerumab is an investigational antibody in Phase III development for early Alzheimer's disease (AD) and a comprehensive data set with an expected readout in mid-2022
The initiative will create an integrated network of Critical Care Units (CCUs) across the Apollo Hospitals network but also in partnership with non-Apollo units in India and overseas
This is the first time in South Asia an indigenously made drone was used to transport Covid-19 vaccines
The filing includes data from PROVENT Phase III trial showing 77% reduction in risk of developing symptomatic Covid-19 with a long-acting antibody combination (non-vaccine)
The first clinical trial is expected to commence in early 2022 both in Europe and the US
The two plots are located in the heart of Gurugram close to Sectors 53 on the Golf Course Road and Sector 56 just minutes away from the other location
Subscribe To Our Newsletter & Stay Updated
